Comparison of [111In]octreotide scintigraphy and [68Ga]DOTATOC PET in GEP-NETs: concordance of Krenning scores and implications for PRRT treatment eligibility
{{output}}
Background: Peptide receptor radionuclide therapy (PRRT) is an established treatment for somatostatin receptor (SSTR)-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs), with eligibility determined by the Krenning s... ...
